Cargando…

The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker

The 31- and 32-nt 5′-fragment of Y4-RNA (Y4RNAfr) exists abundantly in human peripheral blood plasma. Although physiological roles of the plasma Y4RNAfr are not well established, its potential utility as a diagnostic/prognostic marker for acute coronary syndrome was suggested. In this paper, to esta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Tatsuya, Haino, Arisa, Seki, Mineaki, Kurihara, Taro, Hirose, Takayuki, Imai, Yosuke, Ishiguro, Takuro, Chou, Takaaki, Toshima, Muneatsu, Terada, Hiroshi, Nashimoto, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078377/
https://www.ncbi.nlm.nih.gov/pubmed/32206739
http://dx.doi.org/10.1016/j.ncrna.2019.12.001
_version_ 1783507609256460288
author Ishikawa, Tatsuya
Haino, Arisa
Seki, Mineaki
Kurihara, Taro
Hirose, Takayuki
Imai, Yosuke
Ishiguro, Takuro
Chou, Takaaki
Toshima, Muneatsu
Terada, Hiroshi
Nashimoto, Masayuki
author_facet Ishikawa, Tatsuya
Haino, Arisa
Seki, Mineaki
Kurihara, Taro
Hirose, Takayuki
Imai, Yosuke
Ishiguro, Takuro
Chou, Takaaki
Toshima, Muneatsu
Terada, Hiroshi
Nashimoto, Masayuki
author_sort Ishikawa, Tatsuya
collection PubMed
description The 31- and 32-nt 5′-fragment of Y4-RNA (Y4RNAfr) exists abundantly in human peripheral blood plasma. Although physiological roles of the plasma Y4RNAfr are not well established, its potential utility as a diagnostic/prognostic marker for acute coronary syndrome was suggested. In this paper, to establish a normal range of the Y4RNAfr level in plasma, we measured plasma Y4RNAfr levels of 40 healthy persons using the method we have developed, and compared them with other blood test data. From the obtained data, we tentatively regarded <0.1 fmol/ng as normal for the Y4RNAfr level in peripheral blood plasma. And the white blood cell count (WBC) and the C-reactive protein (CRP) level showed moderate positive correlations with the Y4RNAfr level, suggesting that Y4RNAfr could be a potential novel inflammatory marker. We also measured the Y4RNAfr level in peripheral blood plasma from four multiple myeloma patients. The plasma Y4RNAfr level was abnormal in all four myeloma patients, and the levels for two patients were far beyond the normal level. The WBC for each patient was normal and the CRP levels for two patients were normal. These observations together suggest that a high level of Y4RNAfr in peripheral blood plasma and a normal WBC could be indicative of multiple myeloma.
format Online
Article
Text
id pubmed-7078377
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-70783772020-03-23 The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker Ishikawa, Tatsuya Haino, Arisa Seki, Mineaki Kurihara, Taro Hirose, Takayuki Imai, Yosuke Ishiguro, Takuro Chou, Takaaki Toshima, Muneatsu Terada, Hiroshi Nashimoto, Masayuki Noncoding RNA Res Article The 31- and 32-nt 5′-fragment of Y4-RNA (Y4RNAfr) exists abundantly in human peripheral blood plasma. Although physiological roles of the plasma Y4RNAfr are not well established, its potential utility as a diagnostic/prognostic marker for acute coronary syndrome was suggested. In this paper, to establish a normal range of the Y4RNAfr level in plasma, we measured plasma Y4RNAfr levels of 40 healthy persons using the method we have developed, and compared them with other blood test data. From the obtained data, we tentatively regarded <0.1 fmol/ng as normal for the Y4RNAfr level in peripheral blood plasma. And the white blood cell count (WBC) and the C-reactive protein (CRP) level showed moderate positive correlations with the Y4RNAfr level, suggesting that Y4RNAfr could be a potential novel inflammatory marker. We also measured the Y4RNAfr level in peripheral blood plasma from four multiple myeloma patients. The plasma Y4RNAfr level was abnormal in all four myeloma patients, and the levels for two patients were far beyond the normal level. The WBC for each patient was normal and the CRP levels for two patients were normal. These observations together suggest that a high level of Y4RNAfr in peripheral blood plasma and a normal WBC could be indicative of multiple myeloma. KeAi Publishing 2019-12-17 /pmc/articles/PMC7078377/ /pubmed/32206739 http://dx.doi.org/10.1016/j.ncrna.2019.12.001 Text en © 2020 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ishikawa, Tatsuya
Haino, Arisa
Seki, Mineaki
Kurihara, Taro
Hirose, Takayuki
Imai, Yosuke
Ishiguro, Takuro
Chou, Takaaki
Toshima, Muneatsu
Terada, Hiroshi
Nashimoto, Masayuki
The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker
title The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker
title_full The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker
title_fullStr The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker
title_full_unstemmed The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker
title_short The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker
title_sort 31-nucleotide y4-rna fragment in plasma is a potential novel biomarker
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078377/
https://www.ncbi.nlm.nih.gov/pubmed/32206739
http://dx.doi.org/10.1016/j.ncrna.2019.12.001
work_keys_str_mv AT ishikawatatsuya the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT hainoarisa the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT sekimineaki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT kuriharataro the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT hirosetakayuki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT imaiyosuke the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT ishigurotakuro the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT choutakaaki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT toshimamuneatsu the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT teradahiroshi the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT nashimotomasayuki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT ishikawatatsuya 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT hainoarisa 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT sekimineaki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT kuriharataro 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT hirosetakayuki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT imaiyosuke 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT ishigurotakuro 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT choutakaaki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT toshimamuneatsu 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT teradahiroshi 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker
AT nashimotomasayuki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker